ASP Isotopes

ASP Isotopes Days Payable Outstanding

The Days Payable Outstanding (DPO) of ASP Isotopes (ASPI) as of Nov 18, 2026 is 102.75. In the previous year, Days Payable Outstanding (DPO) was 146.49 — a change of -29.86% (lower).

Days Payable Outstanding

102.75

YoY

-29.86%

Last updated:

Days Payable Outstanding (DPO) of ASP Isotopes is 2025 102.75 . Days Payable Outstanding (DPO) of ASP Isotopes was 2024 146.49 . It decreases by -29.86% lower compared to the previous year.

The ASP Isotopes Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2021
1,124.22 USD
Jan 1, 2022
6,814.66 USD
Jan 1, 2023
1,380.06 USD
Jan 1, 2024
146.49 USD
Jan 1, 2025
102.75 USD
The ASP Isotopes Days Payable Outstanding history
YEARDays Payable OutstandingYoY
102.75-29.86%
146.49-89.39%
1,380.06-79.75%
6,814.66+506.17%
1,124.22—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ASP Isotopes Stock analysis

What does ASP Isotopes do? ASP Isotopes, Inc. generates revenue through the development and commercialization of enriched isotopes using its Aerodynamic Separation Process (ASP technology). The company focuses on producing Carbon-14 (C-14), Molybdenum-100 (Mo-100), and Silicon-28 (Si-28) for specialized markets, with plans to expand into Uranium-235 (U-235) for the nuclear energy sector. Its subsidiaries, ASP Isotopes Guernsey Limited and Enriched Energy LLC, handle high-value isotope production and uranium development, respectively. The company licenses ASP technology from Klydon Proprietary Ltd for all isotope-related activities. The target customers for C-14, Mo-100, and Si-28 are highly specialized end markets requiring low-volume, high-value isotopes. Enriched Energy LLC specifically targets the nuclear energy market with uranium products. ASP Isotopes Guernsey Limited focuses on niche applications where isotope enrichment is critical, such as medical and industrial uses. The company’s revenue model relies on the sale of these enriched isotope products to specialized industries rather than mass-market consumers. ASP Isotopes, Inc. operates under a pre-commercial stage, meaning it is still developing its production capabilities and has not yet achieved full-scale commercialization. The company’s initial revenue streams will come from the sale of C-14, Mo-100, and Si-28, with future expansion into U-235 expected to diversify its product portfolio. The Aerodynamic Separation Process (ASP technology) is central to its business model, enabling the enrichment of natural isotopes into higher concentration products for specialized applications. ASP Isotopes is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ASP Isotopes stock

Days Payable Outstanding (DPO) of ASP Isotopes is 102.75 in 2025.

Days Payable Outstanding (DPO) of ASP Isotopes changed from 146.49 to 102.75, representing a -29.86% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) ASP Isotopes since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s ASP Isotopes with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — ASP Isotopes

All Key Metrics — ASP Isotopes